Suchergebnisse - "Chehelgerdi, Mohammad"

PubPharm (42)

1

Comment on "A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer"

enthalten in: BMC cancer | 2024

von Chehelgerdi, M. | Khorramian-Ghahfarokhi, M. | Dehkordi, F. | +1

2

Comment on “A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer”

enthalten in: BMC cancer | 2024

von Chehelgerdi, M. | Khorramian-Ghahfarokhi, M. | Dehkordi, F. | +1

3

Correction : Comprehensive review of CRISPR‑based gene editing: mechanisms, challenges, and applications in cancer therapy

enthalten in: Molecular cancer | 2024

von Chehelgerdi, M. | Chehelgerdi, M. | Khorramian-Ghahfarokhi, M. | +6

ErratumFor: Mol Cancer. 2024 Jan 9;23(1):9. - PMID 38195537

4

New long noncoding RNA biomarkers and ceRNA networks on miR-616-3p in colorectal cancer : Bioinformatics-based study

enthalten in: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences | 2024

von Abdolvand, M. | Chermahini, Z. | Bahaloo, S. | +16

5

Comprehensive review of CRISPR-based gene editing : mechanisms, challenges, and applications in cancer therapy

enthalten in: Molecular cancer | 2024

von Chehelgerdi, M. | Chehelgerdi, M. | Khorramian-Ghahfarokhi, M. | +6

ErratumIn: Mol Cancer. 2024 Feb 27;23(1):43. - PMID 38413951

6

Bioactive chitosan/poly(ethyleneoxide)/CuFe2O4 nanofibers for potential wound healing

enthalten in: Environmental research | 2023

von Sharifi, E. | Jamaledin, R. | Familsattarian, F. | +5

7

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

enthalten in: Molecular cancer | 2023

von Chehelgerdi, M. | Behdarvand Dehkordi, F. | Chehelgerdi, M. | +11

8

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

enthalten in: Molecular cancer | 2023

von Chehelgerdi, M. | Behdarvand Dehkordi, F. | Chehelgerdi, M. | +11

9

Comment on "Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics"

enthalten in: Clinical proteomics | 2023

von Behdarvand Dehkordi, F. | Chehelgerdi, M.

10

Progressing nanotechnology to improve targeted cancer treatment : overcoming hurdles in its clinical implementation

enthalten in: Molecular cancer | 2023

von Chehelgerdi, M. | Chehelgerdi, M. | Allela, O. | +14

1
2
3
4
5
Nächster »
[5]